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In vitro Antiplatelet Activity-Guided F Antiplatelet Activity-Guided F Antiplatelet Activity-Guided F Antiplatelet Activity-Guided F Antiplatelet Activity- . Therefore the experiments in expectorant, diuretic, stomachic, and is used for toothache and this study were designed to evaluate the antiplatelet recommended in vertigo and biliousness 4 . An attempt has activity of various fractions of Melothria maderaspatana been made to study the efficacy of aerial parts of Melothria and try to elucidate the inhibitory mechanism of coumarins maderaspatana in platelet aggregation.
or flavonoids on platelet aggregation.
Blood platelets are involved in haemostasis. The normal The aerial parts of Melothria maderaspatana were haemostatic system limits blood loss by precisely regulated collected from the herbal garden of Sri Ramachandra interactions between components of vessel wall, circulating Medical College and Research Institute, Chennai, and blood platelets and plasma proteins. Platelets can adhere to were cleaned, air dried and powdered. The powdered the walls of the blood vessels, release bioreactive aerial parts were subjected to exhaustive maceration with compounds and aggregate to each other. These properties increase to a well established level in conditions of arterial thrombosis and atherogenesis. Several agonists such as ADP, thrombin, collagen and serotonin induce the release of arachidonic acid, after phospholipase activation through calcium mobilization . The filtrates were collected, distilled and concentrated to get pure and dry extracts. The various fractions of the successive extracts were weighed and preliminary phytochemical screening 8,9 was performed. The result is shown in Table 1 .
Various fractions of Melothria maderaspatana in different concentrations in DMSO were used. ADP, platelet-rich plasma and Tyrode buffer were used 10 . Tyrode buffer was prepared using sodium chloride 149 mM, potassium chloride 2.6 mM, sodium bicarbonate 9.5 mM, glucose 5.5 mM, sodium dihydrogen phosphate 0.5 mM, magnesium chloride 0.6 mM and gelatin 0.25%. The hexane and methanol fractions showed maximum antiplatelet activity at 400 µg/ml concentration, whereas ethyl acetate fraction showed a dose-dependent antiplatelet activity. However, the prevention of platelet aggregation was lesser when compared to standard aspirin at 100 µg/ml. Chloroform fraction did not show protection against platelet aggregation. The coumarins and flavonoids present in ethyl acetate extract and flavonoids in hexane extract might have prevented the adhesion and aggregation of platelets, besides release of
Alkaloids
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The platelet-rich plasma 0.13 × 10 -7 for each assay was resuspended in Tyrode buffer (pH adjusted to 7.4 with 0.25 M HCl). Aggregation of the platelets was induced by ADP at a final concentration of 5 µM. Platelet aggregation was recorded by increasing transmittance value of spectrophotometric measurements. To determine the in vitro antiplatelet aggregation property, 100 µl of the various fractions of the plant, in different concentrations (100 µg/ ml, 200 µg/ml, 400 µg/ml, 500 µg/ml), respectively was added to the platelet suspension at different concentrations for 1 min exposure at 37° before treatment with platelet aggregating agents. Aspirin at 100 µg/ml was used as standard. The results are depicted in figs. 1, 2, 3 and 4. cytoplasmic calcium that stimulates the release of ADP and 5HT. The above result proves that Melothria maderaspatana prevents aggregation of platelets.
Accepted 18 October 2006
